Skip to main content
Clinical Trials/NCT02313181
NCT02313181
Completed
Not Applicable

Early Limited Formula for Treating Lactation Concerns

University of California, San Francisco2 sites in 1 country328 target enrollmentJanuary 7, 2015
ConditionsBreastfeeding

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breastfeeding
Sponsor
University of California, San Francisco
Enrollment
328
Locations
2
Primary Endpoint
Length of breastfeeding duration
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

This is a randomized, controlled trial designed to evaluate a new strategy for promoting continued breastfeeding for mothers and babies who initiated breastfeeding in the newborn period. The new strategy, called Early Limited Formula (ELF), consists of 10mL of formula fed to each baby by syringe after each breastfeeding prior to the onset of mature milk production. The study intervention is discontinued at the onset of mature milk production, and the investigators will then follow mothers and infants for 12 months to assess the effect of ELF on breastfeeding duration, maternal experience and healthcare utilization.

Registry
clinicaltrials.gov
Start Date
January 7, 2015
End Date
October 1, 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Valerie Flaherman

Associate Professor of Pediatrics and Epidemiology and Biostatistics

University of California, San Francisco

Eligibility Criteria

Inclusion Criteria

  • Full term, healthy singleton infant (≥ 37 0/7 weeks gestational age) in well newborn nursery
  • Exclusively breastfeeding (has not received any feedings other than breast milk)
  • Infant is 18-72 hours old
  • Infant has weight loss of ≥75th percentile on delivery mode specific nomogram documented at 12-72 hours of age
  • English-speaking mother

Exclusion Criteria

  • Mothers or infants for whom breastfeeding is not recommended by the clinical team
  • Mothers who have already begun to produce mature breast milk
  • Any formula or water feeding prior to enrollment
  • Infants who have already lost ≥10% of their birth weight
  • Family with no active telephone number (home or cellular)
  • Plan for infant adoption or foster care
  • Mothers \<18 years of age
  • Infant receiving scoring for Narcotic Abstinence Syndrome -

Outcomes

Primary Outcomes

Length of breastfeeding duration

Time Frame: 12 months

The investigators will follow babies for 12 months to determine how long the babies continued breastfeeding

Secondary Outcomes

  • State Trait Anxiety Inventory(1 month)
  • Health care utilization(1 month)
  • Formula use(6 months)

Study Sites (2)

Loading locations...

Similar Trials